Search Results - Nappi, Liberato

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Development of flexible procedures for co-optimizing design and control of fuel cell hybrid vehicles

    Development of flexible procedures for co-optimizing design and control of fuel cell hybrid vehicles by Sorrentino, Marco, Cirillo, Valentina, Nappi, Liberato

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Increased TGF-α as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR-MET Interaction and Activation of MET Signaling in Colon Cancer Cells

    Increased TGF-α as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR-MET Interaction and Activation of MET Signaling in Colon Cancer Cells by TROIANI, Teresa, MARTINELLI, Erika, DE PALMA, Raffaele, D'AIUTO, Elena, BERRINO, Liberato, BIANCO, Roberto, CIARDIELLO, Fortunato, NAPOLITANO, Stefania, VITAGLIANO, Donata, CIUFFREDA, Loreta Pia, COSTANTINO, Sara, MORGILLO, Floriana, CAPASSO, Anna, SFORZA, Vincenzo, NAPPI, Anna

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    AXL is an oncotarget in human colorectal cancer

    AXL is an oncotarget in human colorectal cancer by Martinelli, Erika, Martini, Giulia, Cardone, Claudia, Troiani, Teresa, Liguori, Giuseppina, Vitagliano, Donata, Napolitano, Stefania, Morgillo, Floriana, Rinaldi, Barbara, Melillo, Rosa Marina, Liotti, Federica, Nappi, Anna, Bianco, Roberto, Berrino, Liberato, Ciuffreda, Loreta Pia, Ciardiello, Davide, Iaffaioli, Vincenzo, Botti, Gerardo, Ferraiolo, Fiorella, Ciardiello, Fortunato

    Published in Oncotarget
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi‐targeted kinase inhibitors in pimasertib‐resistant human lung and colorectal cancer cells

    Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi‐targeted kinase inhibitors in pimasertib‐resistant human lun... by Martinelli, Erika, Troiani, Teresa, D'Aiuto, Elena, Morgillo, Floriana, Vitagliano, Donata, Capasso, Anna, Costantino, Sarah, Ciuffreda, Loreta Pia, Merolla, Francesco, Vecchione, Loredana, Vriendt, Veerle, Tejpar, Sabine, Nappi, Anna, Sforza, Vincenzo, Martini, Giulia, Berrino, Liberato, Palma, Raffaele, Ciardiello, Fortunato

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: